ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

AIDS Research Loan Repayment Program

January 10, 1992

NCI CTEP Approved Trials For the Month of May

May 31, 2013

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976